Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
amphetamine sulfate
|
| gptkbp:approvalYear |
2012
|
| gptkbp:ATCCode |
gptkb:N06BA01
|
| gptkbp:brand |
amphetamine sulfate
|
| gptkbp:chemicalClass |
amphetamine
|
| gptkbp:contraindication |
glaucoma
hyperthyroidism history of drug abuse advanced arteriosclerosis moderate to severe hypertension symptomatic cardiovascular disease |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Evekeo
|
| gptkbp:legalStatus |
prescription only
Schedule II controlled substance (US) |
| gptkbp:manufacturer |
gptkb:Arbor_Pharmaceuticals
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
anxiety
loss of appetite insomnia dry mouth increased blood pressure |
| gptkbp:usedFor |
gptkb:attention_deficit_hyperactivity_disorder
obesity narcolepsy exogenous obesity |
| gptkbp:bfsParent |
gptkb:Amphetamine
gptkb:amphetamine |
| gptkbp:bfsLayer |
6
|